These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37600022)

  • 1. Colchicine efficacy comparison at varying time points in the peri-operative period for coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
    Wei ZY; Lai JY; Li YT; Yu XY; Liu YH; Hu JX; Gao BB; Wu JG
    Front Cardiovasc Med; 2023; 10():1156980. PubMed ID: 37600022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials.
    Ma Z; Chen J; Jin K; Chen X
    Front Cardiovasc Med; 2022; 9():947959. PubMed ID: 36176989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention.
    Aw KL; Koh A; Lee HL; Kudzinskas A; De Palma R
    Open Heart; 2022 Jan; 9(1):. PubMed ID: 34992158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis.
    Li Y; Li D; Wang W; Li X; Li P; Zhang Y; Lin Q; Li Y
    Front Cardiovasc Med; 2022; 9():1029387. PubMed ID: 36479564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    Bytyçi I; Bajraktari G; Penson PE; Henein MY; Banach M; ;
    Br J Clin Pharmacol; 2022 Feb; 88(4):1520-1528. PubMed ID: 34409634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Efficacy of Danhong Injections at Different Time-points During the Perioperative Period of Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    He QY; Yu XY; Xiao Z; Sun X; Zhu WF; Yi XQ; Chen Q; Zhang JH; Chen SX; Zhou X; Nie HY; Shang HC; Chen XF
    Front Pharmacol; 2021; 12():643446. PubMed ID: 33995051
    [No Abstract]   [Full Text] [Related]  

  • 8. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y
    Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
    Andreis A; Imazio M; Piroli F; Avondo S; Casula M; Paneva E; De Ferrari GM
    Eur J Prev Cardiol; 2022 Feb; 28(17):1916-1925. PubMed ID: 33779702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis.
    Ullah W; Haq S; Zahid S; Gowda SN; Ottman P; Saleem S; Hamzeh I; Virani SS; Alam M; Fischman DL
    Am J Cardiovasc Drugs; 2021 Nov; 21(6):659-668. PubMed ID: 34151410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
    Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J
    Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of parecoxib and flurbiprofen axetil for perioperative analgesia in children: a network meta-analysis.
    Chen X; Chen P; Chen X; Huang M; Tang K; He Q
    Front Med (Lausanne); 2023; 10():1231570. PubMed ID: 37529243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2y
    Yu Y; Pan D; Bai R; Luo J; Tan Y; Duan W; Shi D
    Front Cardiovasc Med; 2023; 10():1197161. PubMed ID: 37485257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
    Zhu K; Zheng YS; Fang Y
    Medicine (Baltimore); 2020 Oct; 99(44):e22918. PubMed ID: 33126352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Goh CXY; Tan YK; Tan CH; Leow AST; Ho JSY; Tan NHW; Goh S; Ho AFW; Sharma VK; Chan BPL; Yeo LLL; Tan BYQ
    J Thromb Thrombolysis; 2022 Jul; 54(1):183-190. PubMed ID: 35538274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
    Xia M; Yang X; Qian C
    Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine for cardiovascular medicine: a systematic review and meta-analysis.
    Casula M; Andreis A; Avondo S; Vaira MP; Imazio M
    Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation.
    Zhang RS; Weber BN; Araiza-Garaygordobil D; Garshick MS
    Curr Cardiol Rep; 2024 May; 26(5):423-434. PubMed ID: 38573553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine administration for percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Fu C; Wang B
    Am J Emerg Med; 2021 Aug; 46():121-125. PubMed ID: 33744748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.